Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system

Diabetes Technology and Therapeutics

Volumn 11, Issue 1, 2009, Pages 57-62

  Peyrot, Mark ^a,b   Rubin, Richard R ^b  

^a LOYOLA UNIVERSITY MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING SYSTEM RATING QUESTIONNAIRE; BODY WEIGHT; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTINUOUS INFUSION; CONTROLLED STUDY; DEVICE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DELIVERY SYSTEM RATING QUESTIONNAIRE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REAL TIME CONTINUOUS GLUCOSE MONITORING SYSTEM; SATISFACTION; SELF MONITORING; USER ACCEPTANCE QUESTIONNAIRE;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; INSULIN INFUSION SYSTEMS; MONITORING, AMBULATORY; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; QUESTIONNAIRES; SOFTWARE; TREATMENT OUTCOME;

EID: 58149400751     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0002     Document Type: Article

References (23)

1. Pickup JC, Mattock MB, Kerry S: Glycaemic control with continuous subcutaneous insulin infusion compared to intensive insulin injection therapy in type 1 diabetes: a meta-analysis of randomized controlled trials. BMJ 2002;324:705-708.
2. Pickup J, Keen H: Continuous subcutaneous insulin infusion at 25 years: evidence base for expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25:593-598.
3. Boland EA, Grey M, Oesterle A, Frederick L, Tamborlane WV: Continuous subcutaneous insulin infusion: a new way to lower risk of sever hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-1784.
4. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M: Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy: an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002;19:746-751.
5. Schrezenmeir J, Dirting K, Papazov P: Controlled multicenter study on the effect of computer assistance in intensive insulin therapy of type 1 diabetics. Comput Methods Programs Biomed 2002;69:97-114.
6. Peters A, Kerner W: Analytic design and clinical application of an intelligent control system for pharmacotherapy with insulin. Biomed Tech (Berl) 1996;41:42-53.
7. Moreland EC, Volkening LK, Lawlor MT, Chalmers KA, Anderson BJ, Laffel LM: Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial. Arch Intern Med 2006;166:689-695.
8. st century diabetes therapy. Diabetes Care 2005;28:1231-1239.
9. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649.
10. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50.
11. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732.
12. Yates K, Milton AH, Dear K, Ambler G: Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care 2006;29:1512-1517.
13. Chico A, Vidal-Rios P, Subira M, Novials A: The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is no better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-1157.
14. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther 2004;6:105-113.
15. Augstein P, Vogt L, Kohnert KD, Freyse EJ, Heinke P, Salzsieder E: Outpatient assessement of Karlsburg diabetes management system-based decision support. Diabetes Care 2007;30:1704-1708.
16. Peyrot M, Rubin RR: Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care 2005;28:53-58.
17. Peyrot M, Rubin R: Patient-reported outcomes (PRO) for an integrated real-time continuous glucose monitoring/insulin pump (RT-CGM/CSII) system [abstract]. Diabetes 2007; 56(Suppl 1):A122-A123.
18. Pickup J: Are insulin pumps underutilized in type 1 diabetes? Yes. Diabetes Care 2006;29:1449-1452.
19. Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-592.
20. Cohen J: Statistical Power Analysis for the Behavioral Sciences. London: Academic Press, 1969.
21. The Diabetes Research in Children Network (DirecNet) Study Group: Youth and parent satisfaction with clinical use of the GlucoWatch Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005;28:1929-1935.
22. The Diabetes Research in Children Network (DirecNet) Study Group: A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005;28:1101-1106.
23. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Wolpert HA, Buckingham BA: Sensor augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008;10:377-383.